These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31724288)

  • 21. Annual banned-substance review 16
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2024 Jan; 16(1):5-29. PubMed ID: 37985429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stable isotope ratio analysis in sports anti-doping.
    Cawley A
    Drug Test Anal; 2012 Dec; 4(12):891-2. PubMed ID: 23255318
    [No Abstract]   [Full Text] [Related]  

  • 23. Stereoisomers in sports drug testing: Analytical strategies and applications.
    Thomas A; Thevis M
    J Chromatogr A; 2022 Jul; 1674():463154. PubMed ID: 35613502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016.
    Aquino Neto FR; Sarderla VF; Mirotti L; Pizzatti L
    Bioanalysis; 2016 Sep; 8(17):1753-6. PubMed ID: 27491844
    [No Abstract]   [Full Text] [Related]  

  • 25. The analytical chemistry of drug monitoring in athletes.
    Bowers LD
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complementary stable carbon isotope ratio and amount of substance measurements in sports anti-doping.
    Cawley AT; George AV
    Drug Test Anal; 2012 Dec; 4(12):897-911. PubMed ID: 22791679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.
    Thevis M; Thomas A; Schänzer W
    Anal Bioanal Chem; 2013 Dec; 405(30):9655-67. PubMed ID: 23925796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass spectrometry in sports drug testing-Analytical approaches and the athletes' exposome.
    Thevis M; Görgens C; Guddat S; Thomas A; Geyer H
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14228. PubMed ID: 36539355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical techniques in androgen anabolic steroids (AASs) analysis for antidoping and forensic purposes.
    Strano-Rossi S; Fiore C; Chiarotti M; Centini F
    Mini Rev Med Chem; 2011 May; 11(5):451-8. PubMed ID: 21443505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical challenges in sports drug testing.
    Thevis M; Krug O; Geyer H; Walpurgis K; Baume N; Thomas A
    Anal Bioanal Chem; 2018 Mar; 410(9):2275-2281. PubMed ID: 29445832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.
    Thevis M; Schänzer W
    Rapid Commun Mass Spectrom; 2016 Mar; 30(5):635-51. PubMed ID: 26842585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M; Schänzer W
    Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical strategy for detecting doping agents in hair.
    Thieme D; Grosse J; Sachs H; Mueller RK
    Forensic Sci Int; 2000 Jan; 107(1-3):335-45. PubMed ID: 10689585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of legal and illegal stimulating agents in sports.
    Deventer K; Roels K; Delbeke FT; Van Eenoo P
    Anal Bioanal Chem; 2011 Aug; 401(2):421-32. PubMed ID: 21479548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples.
    Hullstein IR; Malerod-Fjeld H; Dehnes Y; Hemmersbach P
    Drug Test Anal; 2015; 7(11-12):1025-9. PubMed ID: 26607218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of GC-EI/MS, GC-EI/MS/MS, LC-ESI/MS/MS, LC-Ag(+) CIS/MS/MS, and GC-ESI/MS/MS for analysis of anabolic steroids in doping control.
    Cha E; Kim S; Kim HJ; Lee KM; Kim KH; Kwon OS; Lee J
    Drug Test Anal; 2015; 7(11-12):1040-9. PubMed ID: 26489966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in equine anti-doping.
    Cawley A
    Drug Test Anal; 2017 Sep; 9(9):1282-1283. PubMed ID: 28631881
    [No Abstract]   [Full Text] [Related]  

  • 39. Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution.
    Oleksak P; Nepovimova E; Valko M; Alwasel S; Alomar S; Kuca K
    Environ Toxicol Pharmacol; 2024 Jun; 108():104447. PubMed ID: 38636744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.
    Cadwallader AB; Lim CS; Rollins DE; Botrè F
    J Anal Toxicol; 2011 Nov; 35(9):594-607. PubMed ID: 22080898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.